Skip to main content
TECON BIOLOGY Co.LTD logo

TECON BIOLOGY Co.LTD — Investor Relations & Filings

Ticker · 002100 ISIN · CNE000001PZ9 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,493 across all filing types
Latest filing 2024-04-09 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002100

About TECON BIOLOGY Co.LTD

https://www.tcsw.com.cn

TECON BIOLOGY Co.LTD operates an integrated industrial chain focused on animal health and nutrition. The company specializes in the research, development, and manufacturing of veterinary biological products, including a comprehensive range of vaccines and diagnostic reagents for livestock. Its operations encompass the production of high-quality animal feed and the management of large-scale breeding programs, with a primary focus on pig farming and meat processing. By leveraging advanced biotechnology and standardized production systems, the company provides comprehensive solutions for livestock management and food safety. Key activities include the formulation of specialized animal nutrition products and the implementation of rigorous biosecurity protocols across its facilities to ensure the quality and reliability of its agricultural outputs.

Recent filings

Filing Released Lang Actions
关于2024年3月份生猪销售简报
Regulatory Filings Classification · 95% confidence The document is a sales brief for March 2024 from Tian Kang Biological Co., Ltd., detailing monthly and cumulative sales volumes and revenues of live pigs. It includes sales data, reasons for sales growth, risk warnings, and a disclaimer that the data is unaudited and for reference only. The document is short (1805 characters) and does not contain comprehensive financial statements or detailed financial analysis. It is a periodic sales update rather than a full financial report or earnings release. It does not announce voting results, management changes, or legal matters. It is not a report publication announcement since it contains substantive data, but the data is limited to sales figures and not full financial results. Therefore, the best fitting category is Regulatory Filings (RNS) as a general regulatory announcement of sales data that does not fit other specific categories.
2024-04-09 Chinese
关于推举董事代行董事长职责的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of the company's chairman and the appointment of another director to act as chairman temporarily. It involves changes in the company's board of directors and management roles. There is no financial data, report, or presentation content. The document fits the category of Board/Management Information (MANG). The document length is short and focused solely on management changes, confirming the classification.
2024-04-08 Chinese
关于董事长辞职的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the resignation of the company's chairman and director, including details about the resignation and its impact on the board. It does not contain financial data, audit information, or report content. It is clearly about a change in senior management. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on management change, confirming this classification.
2024-04-07 Chinese
关于完成工商变更登记并换发营业执照的公告
Share Issue/Capital Change Classification · 95% confidence The document is an official announcement from Tian Kang Bio Co., Ltd. regarding the completion of industrial and commercial registration changes and the issuance of a new business license. It details the change in registered capital due to convertible bond holders converting their bonds into shares, resulting in an increase in registered capital. The document references prior board and shareholder meeting resolutions but does not contain financial statements or detailed financial analysis. It is a formal notification about a capital change and registration update, not a full financial report or earnings release. Therefore, it fits best under the category of Share Issue/Capital Change (SHA). The document length is short and focused on the capital change announcement, not a report publication or regulatory filing of a different nature.
2024-04-02 Chinese
第八届董事会第十四次（临时）会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the 14th interim meeting of the 8th Board of Directors of Tian Kang Bio Co., Ltd. It includes details about the meeting date, attendance, agenda items, voting results, and authorization for financing applications. The document does not contain financial statements or detailed financial data but rather reports on board decisions and approvals. It is not an annual or interim report, earnings release, or audit report. It is not a call transcript or investor presentation. The content fits the category of Board/Management Information (MANG), as it announces board meeting resolutions and management decisions.
2024-04-02 Chinese
关于召开2024年第二次临时股东大会通知
AGM Information Classification · 95% confidence The document is a detailed notice about the convening of the 2024 second extraordinary general meeting of shareholders for Tian Kang Biological Co., Ltd. It includes information about the meeting date, voting procedures, agenda items, registration methods, and proxy forms. There is no financial data or report content, but rather an announcement and instructions related to the shareholder meeting. The document length is 4040 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R), which covers presentations and materials shared during or about the Annual General Meeting or other shareholder meetings.
2024-04-02 Chinese

Browse filings by year

21 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.